Targeting the gut-liver axis in liver disease

被引：310

作者：

Wiest, Reiner ^{[1
]}

Albillos, Agustin ^{[2
]}

Trauner, Michael ^{[3
]}

Bajaj, Jasmohan S. ^{[4
,5
]}

Jalan, Rajiv ^{[6
]}

机构：

[1] Univ Hosp, Gastroenterol, CH-3010 Bern, Switzerland

[2] Hosp Univ Ramon & Cajal, Gastroenterol & Hepatol, Madrid, Spain

[3] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria

[4] Virginia Commonwealth Univ, Richmond, VA USA

[5] McGuire VA Med Ctr, GI Hepatol, Richmond, VA USA

[6] UCL, Inst Hepatol, London, England

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 67卷 / 05期

基金：

欧盟地平线“2020”;

关键词：

Gut-liver-axis; Bacterial translocation; Liver injury; Fibrosis; Cirrhosis; Bile acids; Microbiome; Incretines; Pre-; probiotics; Faecal microbial transplantation; PRIMARY SCLEROSING CHOLANGITIS; NONSELECTIVE BETA-BLOCKERS; RANDOMIZED CONTROLLED-TRIAL; SECRETORY IMMUNOGLOBULIN-A; CONTROLLED CLINICAL-TRIAL; BACTERIAL TRANSLOCATION; HEPATOCELLULAR-CARCINOMA; OBETICHOLIC ACID; HEPATIC-ENCEPHALOPATHY; DOUBLE-BLIND;

D O I：

10.1016/j.jhep.2017.05.007

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The gut-liver axis is widely implicated in the pathogenesis of liver diseases, where it is increasingly the focus of clinical research. Recent studies trialling an array of therapeutic and preventative strategies have yielded promising results. Considering these strategies, the armamentarium for targeting the gut-liver axis will continue to expand. Further clinical trials, translated from our current knowledge of the gut-liver axis, promise an exciting future in liver treatment. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

引用

页码：1084 / 1103

页数：20

共 50 条

[1] The gut-liver axis in hepatobiliary diseases
Ichikawa, Masataka
Okada, Haruka
Nakamoto, Nobuhiro
Taniki, Nobuhito
Chu, Po-Sung
Kanai, Takanori
INFLAMMATION AND REGENERATION, 2024, 44 (01)
[2] The Gut-Liver Axis in Cholestatic Liver Diseases
Blesl, Andreas
Stadlbauer, Vanessa
NUTRIENTS, 2021, 13 (03) : 1 - 32
[3] Targeting Gut-Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension
Kalo, Eric
Read, Scott
Ahlenstiel, Golo
LIVERS, 2021, 1 (03): : 147 - 179
[4] Gut-liver axis signaling in portal hypertension
Simbrunner, Benedikt
Mandorfer, Mattias
Trauner, Michael
Reiberger, Thomas
WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (39) : 5897 - 5917
[5] Targeting the Gut-Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers
Madsen, Bjorn S.
Havelund, Troels
Krag, Aleksander
ADVANCES IN THERAPY, 2013, 30 (07) : 659 - 670
[6] Viral Liver Disease and Intestinal Gut-Liver Axis
Kouroumalis, Elias
Tsomidis, Ioannis
Voumvouraki, Argyro
GASTROINTESTINAL DISORDERS, 2024, 6 (01): : 64 - 93
[7] Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
Paolella, Giulia
Mandato, Claudia
Pierri, Luca
Poeta, Marco
Di Stasi, Martina
Vajro, Pietro
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15518 - 15531
[8] The gut-liver axis in nonalcoholic fatty liver disease: molecular mechanisms and new targets
Schneider, Kai Markus
Trautwein, Christian
GASTROENTEROLOGE, 2020, 15 (02): : 112 - 122
[9] Importance of the gut microbiota in the gut-liver axis in normal and liver disease
Kotlyarov, Stanislav
WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (06)
[10] Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
Delgado, Teresa C.
de las Heras, Javier
Martinez-Chantar, Maria L.
FRONTIERS IN ENDOCRINOLOGY, 2022, 13

← 1 2 3 4 5 →